In spite of the fact that cadaveric donor transplantion carries a rare risk of transferring malignancy to the recipient, it is a serious complication that should be taken into consideration (1-3). In immunocompetent individuals, the possibility of tumor transmission is quite low. However, immunosupression which is required in transplantation increases the risk of tumor transfer between donor and recipient significantly (4,5). It is of vital importance to perform the necessary investigations for malignancy in living or cadaveric donors prior to organ transplantation.
Alan : Sağlık Bilimleri
Dergi Türü : Uluslararası
Benzer Makaleler | Yazar | # |
---|
Makale | Yazar | # |
---|